Genetically Engineered Hematopoietic Stem Cells Deliver TGF‐ <i>β</i> Inhibitor to Enhance Bone Metastases Immunotherapy-Reference-Cited by-同舟云学术

Genetically Engineered Hematopoietic Stem Cells Deliver TGF‐ β Inhibitor to Enhance Bone Metastases Immunotherapy

Published:2022-08-10 Issue:28 Volume:9 Page:2201451
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Wang Beilei¹,Bai Jinyu²,Tian Bo²,Chen Hao²,Yang Qianyu¹,Chen Yitong¹,Xu Jialu¹,Zhang Yue¹,Dai Huaxing¹,Ma Qingle¹,Fei Ziying¹,Wang Heng¹,Xu Fang¹,Zhou Xiaozhong²,Wang Chao¹^ORCID

Affiliation:

1. Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon‐Based Functional Materials & Devices Soochow University 199 Ren'ai Road Suzhou Jiangsu 215123 China

2. Department of Orthopedics The Second Affiliated Hospital of Soochow University Suzhou Jiangsu 215004 China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Second Affiliated Hospital of Soochow University

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202201451

Reference45 articles.

1. Clinical usefulness of bone markers in prostate cancer with bone metastasis

2. Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications

3. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

4. Initial results from a phase II study of nivolumab (NIVO) plus ipilimumab (IPI) for the treatment of metastatic castration-resistant prostate cancer (mCRPC; CheckMate 650).

5. Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterials for bone metastasis;Journal of Controlled Release;2024-09

2. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy;Autoimmunity Reviews;2024-06

3. Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors;Frontiers in Immunology;2024-02-23

4. Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review);International Journal of Oncology;2024-02-13

5. Dual‐Targeting Biomimetic Semiconducting Polymer Nanocomposites for Amplified Theranostics of Bone Metastasis;Angewandte Chemie International Edition;2023-12-06